Innovative Cellular Therapeutics Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding, Subsidiary
- Established
- 2009-08-27
- Employees
- 51
- Market Cap
- -
- Website
- http://www.sidansai.com
CART Therapy in Digestive System Tumors
Not Applicable
Not yet recruiting
- Conditions
- Malignant Neoplasms of Digestive Organs
- Interventions
- Biological: gucy2c cart cells
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Innovative Cellular Therapeutics Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04780529
- Locations
- 🇨🇳
Anhui provincial cancer hospital, Hefei, Anhui, China
Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
Not Applicable
- Conditions
- Leukemia, B-CellLymphoma, B-Cell
- Interventions
- Biological: CD19CART
- First Posted Date
- 2016-06-27
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Innovative Cellular Therapeutics Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02813837
- Locations
- 🇨🇳
Innovative Cellular Therapeutics CO., LTD., Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath